Market-Moving News for September 23rd
Market-Moving News for September 23rd
BDTX: 54% | Black Diamond Therapeutics shares are trading higher after the company announced initial Phase 2 data demonstrating encouraging clinical responses and durability of BDTX-1535 in patients with relapsed/refractory epidermal growth factor receptor-mutant non-small cell lung cancer.
BDTX：54% | Black Diamond Therapeutics的股價走高，此前該公司公佈了初步的第二階段數據，該數據顯示，BDTX-1535 對復發/難治性表皮生長因子受體突變體非小細胞肺癌患者的臨床反應令人鼓舞，耐久性。
VTYX: 42% | Ventyx Biosciences Announces Sanofi Has Agreed To Make A $27M Investment In Co. At An As-Converted Price Of $3.8243 Per Share, Pursuant To Which Sanofi Will Purchase 70,601 Shares Of Series A Non-Voting Convertible Preferred Stock
VTYX：42% | Ventyx Biosciences宣佈賽諾菲已同意向公司投資2700萬美元按每股3.8243美元的折算價格，賽諾菲將根據該價格購買70,601股A系列無表決權可轉換優先股
BHVN: 26% | Biohaven shares are trading higher after the company announced its study of Troriluzole for the treatment of spinocerebellar ataxia in achieved the primary endpoint.
BHVN：26％ | Biohaven宣佈其治療脊髓小腦共濟失調的Troriluzole的研究已達到主要終點後，該公司股價走高。
